Liquidia Corp. (LQDA)
68.66
+0.03
(+0.04%)
USD |
NASDAQ |
Sep 04, 16:00
68.83
+0.17
(+0.25%)
After-Hours: 20:00
Liquidia SG&A Expense (TTM) : 192.66M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 192.66M |
| March 31, 2026 | 174.05M |
| December 31, 2025 | 157.18M |
| September 30, 2025 | 130.14M |
| June 30, 2025 | 110.26M |
| March 31, 2025 | 91.38M |
| December 31, 2024 | 81.57M |
| September 30, 2024 | 77.52M |
| June 30, 2024 | 67.90M |
| March 31, 2024 | 57.20M |
| December 31, 2023 | 44.74M |
| September 30, 2023 | 33.78M |
| June 30, 2023 | 29.97M |
| March 31, 2023 | 27.66M |
| December 31, 2022 | 32.41M |
| September 30, 2022 | 34.69M |
| June 30, 2022 | 32.83M |
| March 31, 2022 | 30.32M |
| December 31, 2021 | 23.11M |
| Date | Value |
|---|---|
| September 30, 2021 | 25.81M |
| June 30, 2021 | 28.08M |
| March 31, 2021 | 28.88M |
| December 31, 2020 | 27.37M |
| September 30, 2020 | 21.99M |
| June 30, 2020 | 17.22M |
| March 31, 2020 | 14.40M |
| December 31, 2019 | 13.60M |
| September 30, 2019 | 10.14M |
| June 30, 2019 | 10.04M |
| March 31, 2019 | 9.626M |
| December 31, 2018 | 8.754M |
| September 30, 2018 | 6.425M |
| June 30, 2018 | 7.146M |
| March 31, 2018 | 5.154M |
| December 31, 2017 | 5.156M |
| September 30, 2017 | 5.156M |
| June 30, 2017 | 2.151M |
| March 31, 2017 | 2.151M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Indivior Pharmaceuticals, Inc. | 591.00M |
| Harmony Biosciences Holdings, Inc. | 272.47M |
| Johnson & Johnson | 25.14B |
| United Therapeutics Corp. | 644.60M |
| Amneal Pharmaceuticals, Inc. | 571.86M |